The Morning Dispatch: Families Turn to Private Schools Amid Uncertainty

Happy Wednesday! We didn’t realize how much you all loved the Presented Without Comment section—we promise to never leave you hanging again! (We had to cut it for space yesterday—our apologies.)

Quick Hits: Today’s Top Stories

  • The United States confirmed 56,105 new cases of COVID-19 yesterday, with 8.1 percent of the 695,586 tests reported coming back positive. An additional 1,383 deaths were attributed to the virus on Tuesday, bringing the pandemic’s American death toll to 156,771.

  • A massive explosion in Beirut, the capital of Lebanon, killed at least 70 people yesterday, injuring thousands more.

  • Results from an early trial showed that a COVID-19 vaccine from biotech company Novavax sparked the development of neutralizing antibodies, which may help prevent coronavirus infection, in each of the 130 volunteers in the study. About 80 percent participants experienced some sort of mild side effects—tenderness at injection site, headaches, fatigue—and Novavax plans to begin Phase 3 trials later this fall.

Try 7 Days Free
Become a Dispatch member for unlimited access to our 10 daily and weekly newsletters, Dispatch Live broadcasts, article comments and community events. JOIN ALREADY A PAID SUBSCRIBER? SIGN IN
Comments (0)
Join The Dispatch to participate in the comments.

There are currently no responses to this article.
Be the first to respond.